Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear

Rapid uptake previously demonstrated by intradermal (ID) drug administration indicates compound delivery within the dermis may have clinical and pharmacological advantages for certain drug therapies. This study is the first clinical trial to evaluate continuous microneedle-based drug infusion, devic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rini, Christopher James, McVey, Elaine, Sutter, Diane, Keith, Stephen, Kurth, Heinz-Joerg, Nosek, Leszek, Kapitza, Christoph, Rebrin, Kerstin, Hirsch, Laurence, Pettis, Ronald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529466/
https://www.ncbi.nlm.nih.gov/pubmed/26037035
http://dx.doi.org/10.1007/s13346-015-0239-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529466/
https://www.ncbi.nlm.nih.gov/pubmed/26037035
http://dx.doi.org/10.1007/s13346-015-0239-x

Ejemplares similares